We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.99%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$688M
AUM Growth
-$26.3M
Cap. Flow
+$3.03M
Cap. Flow %
0.44%
Top 10 Hldgs %
14.02%
Holding
2,132
New
481
Increased
479
Reduced
411
Closed
685

Sector Composition

Rank Sector Weight
1 Technology 9.94%
2 Financials 9.92%
3 Real Estate 8.14%
4 Industrials 7.95%
5 Consumer Discretionary 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTBL
1851
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
-8,783
Closed -$50K
PGTI
1852
DELISTED
PGT, Inc.
PGTI
-4,300
Closed -$62K
NEPT
1853
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
0
ARAV
1854
DELISTED
Aravive, Inc. Common Stock
ARAV
-183
Closed -$17K
GOL
1855
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-3,625
Closed -$17K
RPT
1856
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-10
Closed
PCTI
1857
DELISTED
PCTEL, Inc. Common Stock
PCTI
-3,000
Closed -$22K
CORR
1858
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-19,098
Closed -$604K
ARGO
1859
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-1,650
Closed -$73K
SYNH
1860
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-1,569
Closed -$63K
INFI
1861
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-5,400
Closed -$59K
INFI
1862
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-1,500
Closed -$16K
KDNY
1863
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-140
Closed -$21K
GLOP
1864
DELISTED
GASLOG PARTNERS LP
GLOP
-1,500
Closed -$34K
ISEE
1865
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-1,200
Closed -$62K
ACOR
1866
DELISTED
Acorda Therapeutics
ACOR
-17
Closed -$67K
CSII
1867
DELISTED
Cardiovascular Systems, Inc.
CSII
-12,853
Closed -$340K
PLXP
1868
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-125
Closed -$13K
FCRD
1869
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
-14,500
Closed -$167K
UMPQ
1870
DELISTED
Umpqua Holdings Corp
UMPQ
-950
Closed -$17K
AGTC
1871
DELISTED
Applied Genetic Technologies Corporation
AGTC
-215
Closed -$3K
CLR
1872
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-300
Closed -$13K
TEN
1873
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-6,000
Closed -$345K
DRE
1874
DELISTED
Duke Realty Corp.
DRE
-950
Closed -$18K
CTXS
1875
CALL
DELISTED
Citrix Systems Inc
CTXS
-1,130
Closed -$63K

Similar funds

Prelude Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Prelude Capital Management held 2,132 positions worth $688M, down 3.7% from $714M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management's Q3 2015 filing shows 481 new, 479 increased, 411 reduced and 685 closed positions. Its largest new stake was PRECISION CASTPARTS CORP: 49,226 shares worth $11.3M. The largest sale was DIRECTV COM STK (DE), an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 11% a quarter earlier, followed by Financials and Real Estate.

  • Prelude Capital Management's largest Q3 2015 buy was PRECISION CASTPARTS CORP: 49,226 shares worth $11.3M.
  • Prelude Capital Management added most to KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2015, an estimated $7.66M increase.
  • Prelude Capital Management's biggest Q3 2015 reduction was Total System Services, Inc., cutting an estimated $2.99M.
  • Prelude Capital Management fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $10.3M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $688M portfolio in Q3 2015.
  • Prelude Capital Management opened 481 new positions and closed 685 in Q3 2015.
  • Prelude Capital Management's portfolio value fell 3.7% quarter-over-quarter to $688M.

Based on Prelude Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.